Gene Expression Profiling in Early Breast Cancer
Author Information
Author(s): Yudi Pawitan, Judith Bjöhle, Lukas Amler, Anna-Lena Borg, Suzanne Egyhazi, Per Hall, Xia Han, Lars Holmberg, Fei Huang, Sigrid Klaar, Edison T Liu, Lance Miller, Hans Nordgren, Alexander Ploner, Kerstin Sandelin, Peter M Shaw, Johanna Smeds, Lambert Skoog, Sara Wedrén, Jonas Bergh
Primary Institution: Karolinska Institutet
Hypothesis
Can gene expression profiling identify early breast cancer patients who can safely avoid adjuvant therapy?
Conclusion
The study identified gene expression signatures that can help determine which early breast cancer patients may not need adjuvant therapy.
Supporting Evidence
- A subset of 64 genes was identified that optimally separated patients with good and poor outcomes.
- The expression profile provided better prognostication than traditional clinical factors.
- The findings were validated in independent datasets from Swedish and Dutch patients.
Takeaway
Scientists found a way to look at genes in breast cancer patients to see who really needs extra treatment after surgery and who doesn't.
Methodology
The study analyzed gene expression profiles of 159 breast cancer patients and validated findings in independent cohorts.
Potential Biases
Potential biases in patient selection and treatment assignment could affect the results.
Limitations
The study did not identify patients who would benefit from treatment, and the results may not apply to all breast cancer subtypes.
Participant Demographics
Patients were operated on at the Karolinska Hospital from 1994 to 1996.
Statistical Information
P-Value
0.007
Confidence Interval
1.49–11.77
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website